Magic Formula Showdown: CVS Beats for Retirees in 2026
In a volatile market, CVS Health leads a retirement-focused view of the magic formula, topping Qualcomm and Valero as...
A quick guide helps you compare 401(k) options for your 30s, focusing on fees, employer matches, and potential tax outcomes.
24,750 articlesIn a volatile market, CVS Health leads a retirement-focused view of the magic formula, topping Qualcomm and Valero as...
Investors are testing a new approach to fund life’s milestones—without tapping the core retirement nest egg. The cele...
U.S. regulators move to clear the way for civilian supersonic flights over the continental United States, setting noi...
Investors pushed Microsoft higher as AI software leadership and new deals fueled optimism. This deep dive explains th...
NOBLE, the National Organization of Black Law Enforcement Executives, has endorsed the Clarity Act, becoming the firs...
YieldMax's MSTY ETF continues to pay weekly distributions while its NAV slides, signaling rising risk for investors. ...
As the 2026 World Cup draws global attention, a bold CEO taps the frenzy to build lasting personal-finance products f...
Tether backs Mercado Bitcoin with a $20 million round as Europe tightens rules under MiCA; Bitcoin trades near $62,70...
A fresh framework shows a simple trio of ETFs may match the glide-path goals of target-date funds for those planning ...
Figma posted impressive numbers in early 2026, yet the stock slumped. This article breaks down the drivers behind fig...
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
A new tax window in 2026 may allow a retired couple to realize nearly six figures in long-term gains without federal ...